Latest filing published 02 Jun 2025 for Creo Medical Group plc.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -41.2%Entry £0.17 · Close at T+365 £0.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kevin T. Crofton: trading record in brief
This profile gathers the share dealings of Kevin T. Crofton in Creo Medical Group plc. Between 13 December 2024 and 30 May 2025, the trades on record add up to 2 filings.
The open-market record is one-sided, with 2 purchases and not one sale. The totals do not cover 2 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2025: 1 purchase and no sales on the market.
On 2 June 2025 came the latest disclosure, an open-market purchase in Creo Medical Group plc. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kevin T. Crofton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 0London Stock ExchangeRNS:5676524Canonical exit: 28 Aug 2025 (T+90)
- 0London Stock ExchangeRNS:5469401Canonical exit: 13 Mar 2025 (T+90)
2 of 2 declarations